Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Dermatology Case Answer

Joseph F. Merola, MD  |  Issue: January 2012  |  January 13, 2012

Figure 2: Hematoxylin and eosin stain from punch biopsy of lesional skin demonstrated sarcoidal granulomas, inflamed.

Review the case…

The correct answer is D) Sarcoidosis: This patient’s first presentation of sarcoidosis consisted of skin lesions that were sarcoidal granulomas localized to a single pigment color within her tattoo (note the red pigment areas only are affected). Red tattoo pigment most commonly consists of mercuric sulfide (cinnabar), sienna (ferric hydrate), sandalwood, brazilwood, or organic pigments (aromatic azo compounds). Cutaneous sarcoidosis localized to a tattoo has been well described and several reports demonstrate localization to a single pigment within a given tattoo.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The recommended diagnostic procedure should be a punch biopsy of the affected skin for histopathologic review and culture (see Figure 2). These should include bacterial, fungal, and mycobacterial cultures, since atypical mycobacterial infections from contaminated tattoo materials have been well described. In this case, all tissue cultures were repeatedly negative.

Over time, the chest radiograph demonstrated mediastinal lymphadenopathy consistent with her diagnosis of sarcoid.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Discussion of Other Choices

  1. Majocchi’s granuloma occurs when a superficial fungal/tinea infection extends down into hair follicles and creates a deeper inflammatory granulomatous skin infection. This patient did not have superficial scale or other obvious signs of superficial tinea infection. The biopsy did not demonstrate signs of fungal infection and tissue cultures were negative. Topical antifungal agents may be insufficient to treat these infections.
  2. As discussed above, atypical mycobacterial infection is of particular concern in this patient with a recent tattoo placement. A number of causative mycobacterial strains have been reported, including M. Chelonae, M. Haemophilum, and M. Abscessus.
  3. A granulomatous hypersensitivity reaction may occur, especially to red color–containing pigment (mercury based). This diagnosis was considered until the patient demonstrated other features of sarcoidosis. The possible diagnosis of sarcoidosis should always be considered in these patients.
  4. Hypertrophic lichen planus can present as firm, inflammatory nodules over the lower extremities or more diffusely. They may have a characteristic violaceous appearance. While lichenoid reactions to tattoo pigment have been described, this patient’s pathology results rule out this possibility. Atypical forms of lichen planus, in particular mucosal involvement and hypertrophic variants, may be associated with an underlying hepatitis C infection.

Sources:

  1. Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol. 2005;141:869-872.
  2. Rodríguez-Blanco I, Fernández LC, Suárez-Peñaranda JM, Pérez del Molino ML, Esteban J, Almagro M. Mycobacterium chelonae infection associated with tattoos. Acta Derm Venereol. 2011;91:61-62.

Dr. Merola

Dr. Merola is an instructor in the Department of Dermatology at Harvard Medical School and a fellow in the Rheumatology Division at Brigham and Women’s Hospital, both in Boston. He is the assistant program director for the Combined Medicine-Dermatology training program and a diplomat of the American Board of Dermatology and the American Board of Internal Medicine.

Page: 1 2 | Multi-Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Dermatologymicrobepatient careradiographrheumatologistSarcoidosis

Related Articles

    Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

    November 1, 2013

    Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

    Case Report: A Non-Tuberculous Mycobacterial Infection

    January 20, 2021

    Figure 1. Magnetic resonance imaging of the patient’s left knee shows joint effusion, synovial thickening, and periarticular muscle and soft tissue edema. Tumor necrosis factor-α inhibitors (TNFi’s) have emerged as an integral part of therapeutic strategies for several rheumatic diseases. TNF-α is a pro-inflammatory cytokine implicated in the pathogenesis of rheumatoid arthritis (RA), seronegative spondyloarthropathies…

    Case Report: Pulmonary Sarcoid-Like Reaction in Patient Treated with Etanercept

    April 15, 2022

    Sarcoidosis is a multisystem disease characterized by noncaseating granulomas in affected tissues, mostly involving the lungs and lymph nodes.1,2 The etiology of sarcoidosis remains unknown but is thought to be due to an inflammatory response to an antigen exposure in genetically predisposed individuals.1 Tumor necrosis factor-α (TNF‑α), a pro-inflammatory cytokine, plays an essential role in…

    Sarcoidosis in the Spotlight: Screening, Treatment & More Insights into Sarcoidosis

    June 1, 2021

    An expert discussed the screening and treatment of sarcoidosis and drug-induced sarcoidosis-like reactions during the 2021 ACR State-of-the-Art Clinical Symposium.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences